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Fig. 1: Location of the voxel (red) for the 
acquisition (VOI=20×15×20mm3) of the WM 
(left) and GM (right) MM baseline. 
Fig. 2.a) MM spectrum acquired in white matter region (top, 
64scans, n=5) with metabolite residual clearly identified at long-TE 
(bottom, 32 scans). MM spectrum is presented as the mean (blue) ± 
s.d. (shadow).2.b) Top: Corrected MM baselines acquired in GM 
(red) and WM (blue) region. Bottom: Difference spectrum between 
GM and WM (bottom) exhibits differences in the regions encircled.
Fig. 3: Metabolite concentration (mean±sem., n=5) of  1H 
spectra acquired in white matter region using the MM baseline 
measured in white matter (red) or grey matter blue). Significant 
changes are obersved for Gln, Glu, NAA, Asp. 
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Introduction: Localized 1H spectroscopy allows non-invasive acquisition of NMR spectra and provides direct insight into brain metabolism. At 
short echo time (TE), metabolite resonances are better resolved and 1H spectrum exhibits a broad underlying signal coming from the macromolecules 
(MM). Variations of the MM shape, due to local brain structure in healthy subjects have been previously reported at 1.5T [1]. At 3T and lower field, 
MM can be approximated by a set of mathematical functions but, at higher fields, the improved spectral resolution [2] requires the acquisition of the 
in-vivo MM signal for an accurate quantification of the metabolites. Inaccuracy in the measurement of the MM might lead to systematic errors or 
even prevent simulation of sharp metabolite resonances. Tissue differences of MM in human brain have not been studied at high field, thus to further 
understand their neurochemical profile and their intrinsic properties, they have been acquired with the semi-adiabatic SPECIAL (SPin Echo full 
Intensity Acquired Localized Sequence) [3], preceded by an inversion pulse, in two different tissues (white matter and grey matter). The aim of this 
study is to compare MM baselines acquired in two different tissues (WM and GM) and to evaluate the potential differences on the LCModel (S. 
Provencher Inc, USA) quantification of the metabolites. 
 
Materials and Methods: Ten healthy subjects (8 men, 2 women aged 20 to 28 years) gave informed 
consent according to the procedure approved by the local ethics committee. A home-built shielded 
quadrature transmit/receive surface RF coil (R=6cm) was used to measure spectra in a 7T Siemens 
scanner. Two locations in the occipital lobe were investigated, predominantly grey matter (GM) or white 
matter (WM), using five subjects for each (fig 1). MP2RAGE [4] was first performed to determine the 
composition of the voxel of interest by segmentation of 3D images in terms of WM, GM and cerebral-
spinal fluid. First and second order shims were adjusted using FASTMAP [5]. MM spectra were 
acquired in the aforementioned locations using the IR semi-adiabatic SPECIAL sequence 
(TR/TI/TE=7500/950/12ms, BW=4000Hz, vector size=2048pts, 32×2 scans, 
VOI=20×15×20mm3) employing VAPOR water and outer volume suppression [6]. 
The residual metabolite spectrum was obtained using the same sequence parameters 
except of a long-TE (TE=30ms, 16×2 scans). In vivo 1H spectrum were acquired with 
the standard semi-adiabatic SPECIAL (TR/TE=7500/12ms, 16×2 scans, no 
inversion). The individual 1H MR spectra were frequency and phase corrected before 
averaging, using Matlab. Correction of the MM spectrum was performed with jMRUI 
using AMARES by fixing the linewidth, the frequency, the phase and the amplitude 
of the Lorentzian functions. Metabolites were quantified using LCModel with a basis 
set of simulated spectra of 21 metabolites and the corrected macromolecule baseline 
(WM or GM). A concentration of Creatine of 8.5µmol/g was used as an internal 
reference. Statistical test were based on a paired ANOVA, for testing the relevance of 
the choice of a local baseline on the quantification.  
 
Results and Discussion: Shimming resulted in typical water linewidths of 12-13.5 
Hz. The location of the voxel and the placement of OVS bands were carefully set to 
minimize lipid contamination. 1H spectra with lipid contamination were discarded. 
The mean content of WM and GM in their respective voxel was 60±2% and 75±5% 
(mean±s.d., n=5). The experiment is highly reproducible and the acquired MM 
baselines seemed fairly constant between the healthy subjects (small standard 
deviation, scale to MM01 at 0.91ppm, fig. 2.a top). An optimum inversion time was 
set to 950ms, leading to a MM spectrum with the smallest metabolite residuals. The latter were identified at long-TE (fig. 2.a bottom) and due to the 
long T1. Information on metabolite concentration and their T1 values could be extracted from the MM spectra. For instance, the short T1 and the 
higher concentration of NAAG in WM compare to GM [7] generated a peak at 2.2ppm in WM (fig. 2.b) but not GM baseline. Once residuals were 
assigned to specific metabolites, a correction was applied with jMRUI using AMARES with a set of Lorentzian functions. The comparison between 
the corrected MM baselines (fig. 2.b) revealed a slight variability in the shape with a higher concentration of macromolecules for GM in the region 
1.5-1.6ppm and 2.3-2.6ppm. The MM baselines were then inserted into the basis sets of LCModel to quantify the 1H NMR spectra. Depending on the 
choice of the baseline (WM or GM), small (within the standard deviation) but 
significant (p<0.001) differences were detected in the metabolite quantification (fig. 3) 
for Glu, Gln, NAA (<10%) and Asp (<20%) revealing that the macromolecule signal 
difference between WM and GM at 2.3-2.6ppm has a direct influence on the 
quantification of the metabolites. These observed tissue MM differences (fig. 2.b) are 
in agreement with the previous study at 1.5T [1].  
Based on this preliminary experiment and given the small observed changes on the 
quantification, we conclude that a general in vivo measured MM baseline seems 
sufficient to ensure a reliable quantification of the metabolites in the human brain at 7T.  
References and Acknowledgements: [1] Hofmann et al., 2001 [2] R. Gruetter et al., 
JMR, 2007 [3] V. Mlynarik et al., MRM, 2006 [4] Marques JP et al., Neuroimage, 2010 [5] R. 
Gruetter et al., MRM, 1993 [6] I. Tkac et al, AMR,  2005 [7] P.J.W. Pouwels et al., NMR in 
BioMed. 10:73-78, 1997. Supported by CIBM of the UNIL, UNIGE, HUG, CHUV, EPFL, the 
Leenaards and Jeantet Foundations and SNF grant 131087. 
